4/A//SEC Filing
Stancic Ana 4/A
Accession 0000930413-12-000231
CIK 0000727510other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 6:48 PM ET
Size
6.7 KB
Accession
0000930413-12-000231
Insider Transaction Report
Form 4/AAmended
Stancic Ana
Senior VP, Finance and CFO
Transactions
- Award
Employee Stock Option (Right to Buy)
2011-11-17+125,000→ 125,000 totalExercise: $6.37Exp: 2021-11-17→ Common Stock (125,000 underlying)
Footnotes (4)
- [F1]Options granted by the Issuer pursuant to its 2011 Stock Option and Incentive Plan and qualified under Rule 16b-3(d).
- [F2]The options will vest in four (4) tranches. Of the 125,000 options granted, 31,250 options will vest on November 17, 2012, 31,250 options will vest on November 17, 2013, 31,250 options will vest on November 17, 2014, and the remaining 31,250 options will vest on November 17, 2015, in each case if the Reporting Person remains employed by the Issuer on such date.
- [F3]The Reporting Person's Form 4 filed on November 21, 2011 incorrectly reported that the expiration date of the stock options was November 17, 2011.
- [F4]The Reporting Person's Form 4 filed on November 21, 2011 incorrectly reported that the Reporting Person beneficially owned 155,000 of the subject stock options.
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeother
Related Parties
1- filerCIK 0001320271
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 6:48 PM ET
- Size
- 6.7 KB